Related Experiment Video
Updated: May 30, 2026
![Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F60445.jpg&w=3840&q=50)
Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)
Published on: December 19, 2019
Chk1 is essential for chemical carcinogen-induced mouse skin tumorigenesis
L M Tho1, S Libertini, R Rampling
1Beatson Institute for Cancer Research, Bearsden, Glasgow, UK.
Abstract:
Chk1 is a key regulator of DNA damage checkpoint responses and genome stability in eukaryotes. To better understand how checkpoint proficiency relates to cancer development, we investigated the effects of genetic ablation of Chk1 in the mouse skin on tumors induced by chemical carcinogens. We found that homozygous deletion of Chk1 immediately before carcinogen exposure strongly suppressed benign tumor (papilloma) formation, and that the few, small lesions that formed in the ablated skin always retained Chk1 expression. Remarkably, Chk1 deletion rapidly triggered spontaneous cell proliferation, γ-H2AX staining and apoptosis within the hair follicle, a principal site of origin for carcinogen-induced tumors. At later times, the ablated skin was progressively repopulated by non-recombined Chk1-expressing cells and ultimately normal sensitivity to tumor induction was restored when carcinogen treatment was delayed. In marked contrast, papillomas formed normally in Chk1 hemizygous skin but showed an increased propensity to progress to carcinoma. Thus, complete loss of Chk1 is incompatible with epithelial tumorigenesis, whereas partial loss of function (haploinsufficiency) fosters benign malignant tumor progression.
Insights
Complete loss of Chk1 suppresses tumor formation in mouse skin, while partial loss promotes malignant progression. This highlights Chk1
Area of Science:
- Molecular Biology
- Cancer Research
- Genetics
Background:
- Checkpoint kinase 1 (Chk1) is crucial for DNA damage response and maintaining genome stability in eukaryotes.
- Understanding Chk1's role in checkpoint proficiency is vital for cancer development insights.
- Investigating Chk1's function in mouse skin tumorigenesis induced by chemical carcinogens.
Purpose of the Study:
- To determine the impact of complete Chk1 gene ablation on chemically induced skin tumors.
- To assess the effect of Chk1 haploinsufficiency on benign tumor progression to carcinoma.
Main Methods:
- Genetic ablation of Chk1 in mouse skin prior to carcinogen exposure.
- Analysis of tumor formation, cell proliferation, apoptosis, and DNA damage markers (γ-H2AX).
- Evaluation of Chk1 expression in developing tumors and assessment of tumor progression in hemizygous models.
Main Results:
- Complete Chk1 deletion significantly suppressed benign tumor (papilloma) formation.
- Tumors in Chk1-ablated skin retained Chk1 expression; deletion induced transient proliferation, apoptosis, and γ-H2AX staining.
- Papillomas in Chk1 hemizygous skin showed increased progression to carcinoma.
Conclusions:
- Complete loss of Chk1 function is incompatible with epithelial tumorigenesis initiation.
- Partial loss of Chk1 function (haploinsufficiency) promotes the progression of benign tumors to malignant carcinomas.
- Chk1 plays a dual role in cancer development, suppressing initiation but fostering progression upon partial loss.
Related Concept Videos
Mutagenicity and Carcinogenicity
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

